Pediatric Pulmonary Vascular Disease

Spontaneous neonatal pulmonary arterial thrombosis – cases, mechanisms, and literature review

Ali Abdelhafiz, Alexis L. Benscoter, Sarosh P. BatlivalaCincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine.United States Cardiology in the YoungCardiol Young 2023; DOI: 10.1017/S1047951123002639 AbstractSpontaneous pulmonary artery thrombosis in neonates is rare and can be life-threatening. Clinical presentation may mimic pulmonary hypertension or CHD. Further, not all children present with identifiable risk […]

Spontaneous neonatal pulmonary arterial thrombosis – cases, mechanisms, and literature review Read More »

Vasopressin versus epinephrine during neonatal cardiopulmonary resuscitation of asphyxiated post-transitional piglets

Megan O’Reilly, Tze-Fun Lee, Po-Yin Cheung, Georg M. SchmolzerRoyal Alexandra Hospital and University of Alberta.Canada Resuscitation PlusResus Plus 2023; 15DOI: 10.1016/j.resplu.2023.100427 AbstractBackground: Epinephrine is currently the only recommended cardio-resuscitative medication for use in neonatal cardiopulmonary resuscitation (CPR), as per the consensus of science and treatment recommendations. An alternative medication, vasopressin, might be beneficial in neonatal CPR due

Vasopressin versus epinephrine during neonatal cardiopulmonary resuscitation of asphyxiated post-transitional piglets Read More »

Pre-Flight Hypoxemia Challenge Testing in Bronchopulmonary Dysplasia

Jonathan C. Levin, Catherine A. Sheils, Lystra P. HaygenBoston Children’s Hospital and Brigham and Women’s Hospital.United States PediatricsPediatrics 2023; 152DOI: 10.1542/peds.2022-061001 AbstractBackground and objectives: Former premature infants with bronchopulmonary dysplasia (BPD) are at risk for hypoxemia during air travel, but it is unclear until what age. We aimed to determine pass rates for high altitude simulation testing

Pre-Flight Hypoxemia Challenge Testing in Bronchopulmonary Dysplasia Read More »

A mother and daughter with the p.R443X mutation of mucopolysaccharidosis type II: Genotype and phenotype analysis

Young Bae Sohn, Su Jin Kim, Sung Won Park, Hyung-Doo Park, Chang-Seok Ki, Chi Hwa Kim, Seung Won Huh, Sunghee Yeau, Kyung-Hoon Paik, Dong-Kyu JinSamsung Medical Center. Republic of Korea American Journal of Medical GeneticsAm J Med Genet 2010; 152A: 3129-3132DOI: 10.1002/ajmg.a.33589 AbstractMucopolysaccharidosis type II (Hunter syndrome) is a lysosomal storage disease caused by a deficiency

A mother and daughter with the p.R443X mutation of mucopolysaccharidosis type II: Genotype and phenotype analysis Read More »

Successful pediatric single-lung transplantation with previous contralateral pneumonectomy, using controlled “donation after cardiac death” lung, for congenital pulmonary vein stenosis

Amit Pawale, Michael McKean, John Dark, Asif HasanFreeman Hospital.United Kingdom Journal of Thoracic and Cardiovascular SurgeryJ Thorac Cardiovasc Surg 2010; 139: e125-e126DOI: 10.1016/j.jtcvs.2009.06.006 AbstractAbstract Not Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary HypertensionSurgical and Catheter-mediated Interventions for Pulmonary Vascular DiseaseLung Transplantation for Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular Disease Fresh or

Successful pediatric single-lung transplantation with previous contralateral pneumonectomy, using controlled “donation after cardiac death” lung, for congenital pulmonary vein stenosis Read More »

Drug-eluting stents ameliorate pulmonary vein stenotic changes in pigs in vivo

Takeshi Furukawa, Masahiko Kishiro, Hideo Fukunaga, Masahiro Ohtsuki, Ken Takahashi, Katsumi Akimoto, Toshiaki Shimizu, Shiori Kawasaki, Toshio KumasakaJuntendo University School of Medicine.Japan Pediatric CardiologyPediatr Cardiol 2010; 31: 773-779DOI: 10.1007/s00246-010-9695-8 AbstractThe outcome of stent implantation for pulmonary vein stenosis (PVS) in children remains poor. Several reports describe placing drug-eluting stents to treat PVS, but their effectiveness remains

Drug-eluting stents ameliorate pulmonary vein stenotic changes in pigs in vivo Read More »

First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate

Goetz Christoph Mueller, Ali Dodge-Khatami, Jochen WeilUniversity Heart Center Hamburg.Germany Cardiology in the YoungCardiol Young 2010; 20: 455-458DOI: 10.1017/S1047951110000703 AbstractPaclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a

First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate Read More »

Infantile form of scimitar syndrome with contralateral pulmonary vein stenosis

I. Ricardo Argueta-Morales, Lauren C. Meador, David G. Nykanen, William M. DeCampliArnold Palmer Hospital for Children.United States Pediatric CardiologyPediatr Cardiol 2010; 31: 550-552DOI: 10.1007/s00246-009-9630-z AbstractInfantile scimitar syndrome (SS) carries significant mortality. Consistent management guidelines have not been well established, and outcomes continue to be disappointing. We present our experience managing an SS patient with complex anatomy

Infantile form of scimitar syndrome with contralateral pulmonary vein stenosis Read More »

Total anomalous pulmonary venous connection: morphology and outcome from an international population-based study

Anna N. Seale, Hideki Uemura, Steven A. Webber, John Partridge, Michael Roughton, Siew Y. Ho, Karen P. McCarthy, Sheila Jones, Lynda Shaughnessy, Jan Sunnegardh, Katarina Hanseus, Hakan Berggren, Sune Johansson, Michael L. Rigby, Barry R. Keeton, Piers E. F. Daubeney, on behalf of the British Congenital Cardiac AssociationRoyal Brompton Hospital. United Kingdom and Sweden CirculationCirculation 2010; 122: 2718-2726DOI: 10.1161/CIRCULATIONAHA.110.940825 AbstractBackground: Late mortality after repair of total anomalous pulmonary venous connection is frequently associated with pulmonary venous

Total anomalous pulmonary venous connection: morphology and outcome from an international population-based study Read More »

Treatment of pulmonary vein stenosis with expanded polytetrafluoroethylene covered stents

Brent M. Gordon, John W. MooreRady Children’s Hospital and University of California, San Diego.United States Catheterization and Cardiovascular InterventionsCatheter Cardiovasc Interv 2010; 75: 263-267DOI: 10.1002/ccd.22240 AbstractAtrium expanded polytetrafluoroethylene covered stents were implanted in the stenotic pulmonary veins (n = 5) of three patients. Use of this device was feasible in infants and the procedure was well-tolerated

Treatment of pulmonary vein stenosis with expanded polytetrafluoroethylene covered stents Read More »

Scroll to Top